By Gina Shaw
A mathematical model developed by researchers at Loyola University in Chicago can predict the length of time patients with hepatitis C virus (HCV) must remain on direct-acting antiviral (DAA) drugs to achieve sustained virologic response, according to a new study.
The investigators used early viral kinetic analysis to test study participants—58 people with HCV being treated at three medical centers in France—for blood levels of the virus at the start of the study, on the